查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600607

临床微生物学市场：按产品类型、检体类型、最终用户、应用划分 - 全球预测 2025-2030

Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年临床微生物学市场价值为78亿美元，预计到2024年将达到86.8亿美元，复合年增长率为10.91%，到2030年将达到161.2亿美元。

临床微生物学的范围包括引起人类疾病的微生物的研究和应用，例如细菌、病毒、真菌和寄生虫。这一需求源于日益增长的公共卫生问题、抗生素抗药性以及对快速诊断和治疗解决方案的需求。主要应用是诊断、感染预防和控制以及抗菌药物敏感性测试，服务于医院、诊断实验室和生物技术公司。关键的市场成长要素包括分子诊断的进步、感染疾病盛行率的增加以及政府控制疾病传播的努力。对病原检测和分类方面的即时检测和技术创新的需求不断增长，正在创造巨大的商机。例如，使用电化学和光学生物感测器进行诊断可以提供竞争优势。然而，新兴市场面临先进诊断技术高成本、缺乏熟练人员以及严格法律规范等限制，阻碍了其开发和采用。此外，病原菌的快速突变率对诊断准确性和治疗效果的稳定性提出了挑战。对于相关人员来说，透过投资培训计划和追求监管协调来解决这些限制至关重要。创新可以透过增强快速诊断技术、为资源匮乏环境开发经济实惠的解决方案以及利用巨量资料分析进行预测诊断来推动。基因定序、人工智慧主导的诊断工具和个人化医疗的研究进展为大幅成长提供了途径。随着学术界、工业界和医疗机构之间的合作不断增加，以及推动创新的竞争压力，市场呈现出动态的特征。为了确保永续成长和市场渗透，公司正在策略性地投资于研发，强调开拓共用的伙伴关係，并开拓以医疗基础设施不足但需求不断增长为特征的前沿领域。

主要市场统计
基准年[2023] 78亿美元
预测年份 [2024] 86.8亿美元
预测年份 [2030] 161.2亿美元
复合年增长率（%） 10.91%

市场动态：揭示快速发展的临床微生物学市场的关键市场洞察

供需的动态交互作用正在改变临床微生物学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加临床微生物学在感染疾病管理与控制的应用
    • 促进政府和私人组织在癌症诊断和研究方面的支持和倡议
  • 市场限制因素
    • 缺乏熟练的专业人员、设备和基础设施
  • 市场机会
    • 临床微生物学产品和製程的技术进步
    • 照护现场微生物检测简介
  • 市场挑战
    • 临床微生物实验室的品质保证与控制问题

波特五力：驾驭临床微生物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对临床微生物学市场的外部影响

外部宏观环境因素在塑造临床微生物学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解临床微生物学市场的竞争格局

临床微生物学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵临床微生物学市场供应商的绩效评估

FPNV定位矩阵是评估临床微生物学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加临床微生物学在感染疾病管理与控制的应用
      • 政府和私人组织对癌症诊断和研究的积极支持和努力
    • 抑制因素
      • 缺乏熟练的专业人员、设备和基础设施
    • 机会
      • 临床微生物学产品和製程的技术进步
      • 照护现场微生物检测简介
    • 任务
      • 临床微生物实验室的品质保证与控制问题
  • 市场区隔分析
    • 产品：实验室设备在临床微生物学评估中的使用
    • 检体类型：首选血清样本进行血清学检测，以检测过去或目前的感染情况
    • 最终用户：在实验室和实验室中应用临床微生物学，提供感染疾病病理学的详细信息
    • 应用：识别致病病原体增加了临床微生物学在胃肠道疾病诊断的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章临床微生物学市场：副产品

  • 装置
  • 试剂

第七章临床微生物学市场标本类型

  • 血
  • 体液
  • 脑脊髓液
  • 屎
  • 唾液
  • 血清
  • 滑液
  • 尿

第八章临床微生物学市场：依最终使用者分类

  • 学术研究所
  • 医院和护理提供者
  • 研究所

第九章临床微生物学市场：依应用分类

  • 自体免疫疾病
  • 心臟病学
  • 糖尿病
  • 药物测试
  • 消化系统疾病
  • 肾臟病学
  • 肿瘤学
  • 牙周病
  • 呼吸系统疾病
  • 性行为感染传染病

第十章美洲临床微生物学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太临床微生物学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲临床微生物学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 威奇托州立大学 MDL 实验室转向微生物学。
    • 剑桥Start-Ups赢得了开发新诊断方法的资金。
    • 微生物学会与印度班加罗尔科学研究所签署转型协议
    • Hardy Diagnostics 与 Premier 签署手册微生物学协议
    • 医学微生物学系推出了四个总价值 680 万美元的新计划和一个新网站。
    • ASM 资助包容性微生物学领导计画。
    • MAESTRIA 是 Biomerieux 开发的新一代微生物学中间件，可优化实验室工作流程并改善患者照护。
    • Beckman Coulter 和 MeMed 将扩大经过验证的宿主免疫反应诊断的使用范围，这些诊断可以区分病毒和细菌感染。
    • BD 为微生物实验室安装全自动机器人轨道系统。
    • FASTinov 与 Beckman Coulter Life Sciences 合作，将超快 2h-AST 创新技术引入临床微生物实验室。
    • 北部计划开设一个莱姆病和蜱传疾病的多学科治疗中心。
    • Bio-Rad 扩大了 Abbott 诊断平台的品质控制覆盖范围。
    • 联邦资金将增强亚伯达大学应对高传染性病原体的能力。
    • 牛津大学获得 1.22 亿英镑（1.3663 亿美元）的医疗保健研究资金。
    • Sci-Tech Daresbury 旗下的 Perfectus Biomed Group 已被医疗设备测试领域的全球领导者 NAMSA 收购。
    • HORIBA Veterinary 为难以诊断的寄生虫增加了新的快速 PCR 检测。
    • ValitaCell 加入贝克曼库尔特生命科学公司。
    • Global Access Diagnostics 从 Bio-Rad Laboratories 获得了 IT-LEISH 快速诊断测试的製造权。
    • SSI Diagnostica 持续强劲成长。
    • BD 和 Accelerate Diagnostics 宣布建立全球商业合作伙伴关係。
    • SGS 在亚利桑那州凤凰城开设了一个新的微生物实验室。
    • 以色列：欧盟向以色列微生物诊断公司 Pocared 提供 2,200 万欧元（2,426 万美元）。
    • DCN Dx 收购微生物检测产品公司 Biomed Diagnostics。
    • 生物梅里埃透过收购 Specific Diagnostics（创新企业），加强了对抗抗菌素抗药性的努力。
    • 美国国立卫生研究院 (NIH) 资助新的结核病研究和发展中心。
    • Raue 为 Sonic Healthcare 收购 Diagnosticum Laboratory Group 提供顾问服务。
    • ATCC 宣布与 QIAGEN 建立合作伙伴关係，以扩展其生物资讯资料平台。
    • Hardy Diagnostics 现在提供 BioCode MDx-3000。
    • 默克宣布对其生命科学业务部门进行组织变革，以加强其 CDMO 产品并加速未来成长。
    • COPAN Diagnostics 宣布临床微生物学人工智慧发展又迈出了重要一步。

公司名单

  • ELITech Group
  • Beckman Coulter, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Rapid Micro Biosystems, Inc.
  • Kyokuto Pharmaceutical Industrial Co., Ltd.
  • Hardy Diagnostics
  • SSI Diagnostica A/S
  • QIAGEN NV
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Liofilchem Srl
  • 3M Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Abbott Laboratories
  • COPAN Diagnostics Inc.
  • Cardinal Health, Inc.
  • Vircell SL
  • TCS Biosciences Ltd.
  • Clinichem Ltd.
  • Advanced Instruments, LLC
  • B. Braun SE
  • Pro Lab Diagnostics Inc.
  • Prestige Diagnostics UK Ltd.
  • Laboratorios Conda, SA
  • Becton, Dickinson and Company
  • Shimadzu Corporation
  • HORIBA, Ltd.
  • Diagnostica Longwood SL
Product Code: MRR-4312A385A416

The Clinical Microbiology Market was valued at USD 7.80 billion in 2023, expected to reach USD 8.68 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 16.12 billion by 2030.

The scope of clinical microbiology encompasses the study and application of microorganisms causing diseases in humans, spanning bacteria, viruses, fungi, and parasites. Its necessity arises from growing public health concerns, antibiotic resistance, and the need for rapid diagnostic and therapeutic solutions. Applications are primarily in diagnostics, infection prevention and control, and antimicrobial susceptibility testing, serving hospitals, diagnostic labs, and biotechnology companies. Key market growth factors include advancements in molecular diagnostics, increased prevalence of infectious diseases, and government initiatives to curb disease spread. The rising demand for point-of-care testing and technological innovation in detecting and categorizing pathogens offers significant opportunities. For instance, leveraging electrochemical and optical biosensors in diagnostics could provide competitive advantages. The market, however, faces limitations such as high costs of advanced diagnostic techniques, a shortage of skilled personnel, and stringent regulatory frameworks that can impede development and rollout. Moreover, the rapid mutation rates of pathogens present challenges for consistent diagnostic accuracy and therapeutic efficacy. It's pivotal for stakeholders to address these limitations by investing in training initiatives and pursuing regulatory harmonization. Innovation can be driven by enhancing rapid diagnostic technologies, developing affordable solutions for low-resource settings, and harnessing big data analytics for predictive diagnostics. Further research into genome sequencing, AI-driven diagnostic tools, and personalized medicine can provide substantive growth avenues. The market exhibits a dynamic nature with increasing collaborative efforts between academia, industry, and healthcare facilities, fostering innovation against a backdrop of competitive pressures. Businesses are recommended to invest strategically in R&D, focus on partnerships for technology sharing, and explore untapped regional markets characterized by inadequate health infrastructure but growing demand, to ensure sustainable growth and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 7.80 billion
Estimated Year [2024] USD 8.68 billion
Forecast Year [2030] USD 16.12 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Microbiology Market

The Clinical Microbiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of clinical microbiology in managing and controlling infectious diseases
    • Favorable government and private organizations support, and initiatives in cancer diagnosis and research
  • Market Restraints
    • Limited availability of skilled professionals, equipment and infrastructure
  • Market Opportunities
    • Technological advancement in clinical microbiology products and processes
    • Introduction of point-of-care microbiology testing
  • Market Challenges
    • Problems concerning quality assurance and management in clinical microbiology laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Microbiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Microbiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Microbiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Microbiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Microbiology Market

A detailed market share analysis in the Clinical Microbiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Microbiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Microbiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include ELITech Group, Beckman Coulter, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Rapid Micro Biosystems, Inc., Kyokuto Pharmaceutical Industrial Co., Ltd., Hardy Diagnostics, SSI Diagnostica A/S, QIAGEN N.V., Merck KGaA, F. Hoffmann-La Roche Ltd., Liofilchem S.r.l., 3M Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Abbott Laboratories, COPAN Diagnostics Inc., Cardinal Health, Inc., Vircell S.L., TCS Biosciences Ltd., Clinichem Ltd., Advanced Instruments, LLC, B. Braun SE, Pro Lab Diagnostics Inc., Prestige Diagnostics U.K. Ltd., Laboratorios Conda, S.A., Becton, Dickinson and Company, Shimadzu Corporation, HORIBA, Ltd., and Diagnostica Longwood S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents.
  • Based on Specimen Type, market is studied across Blood, Body fluids, Cerebrospinal Spinal Fluid, Fecal, Saliva, Serum, Synovial Fluid, and Urine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Care Providers, and Laboratories.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, Gastrointestinal Diseases, Nephrology, Oncology, Periodontal Diseases, Respiratory Diseases, and Sexually Transmitted Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
      • 5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in clinical microbiology products and processes
      • 5.1.3.2. Introduction of point-of-care microbiology testing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
    • 5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
    • 5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
    • 5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Microbiology Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents

7. Clinical Microbiology Market, by Specimen Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Body fluids
  • 7.4. Cerebrospinal Spinal Fluid
  • 7.5. Fecal
  • 7.6. Saliva
  • 7.7. Serum
  • 7.8. Synovial Fluid
  • 7.9. Urine

8. Clinical Microbiology Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Hospitals & Care Providers
  • 8.4. Laboratories

9. Clinical Microbiology Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. Gastrointestinal Diseases
  • 9.7. Nephrology
  • 9.8. Oncology
  • 9.9. Periodontal Diseases
  • 9.10. Respiratory Diseases
  • 9.11. Sexually Transmitted Diseases

10. Americas Clinical Microbiology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Microbiology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Microbiology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wichita State's MDL Lab Shifting To Microbiology.
    • 13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
    • 13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
    • 13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
    • 13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
    • 13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
    • 13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomerieux to Optimize Laboratory Workflow and Improve Patient Care.
    • 13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
    • 13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
    • 13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
    • 13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
    • 13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
    • 13.3.13. Federal Funds Set To Boost U of A's Ability To Handle Highly Infectious Pathogens.
    • 13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
    • 13.3.15. Sci-Tech Daresbury's Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
    • 13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
    • 13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
    • 13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
    • 13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
    • 13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
    • 13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
    • 13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
    • 13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
    • 13.3.24. bioMerieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
    • 13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
    • 13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
    • 13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
    • 13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
    • 13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
    • 13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.

Companies Mentioned

  • 1. ELITech Group
  • 2. Beckman Coulter, Inc.
  • 3. Agilent Technologies, Inc.
  • 4. Thermo Fisher Scientific Inc.
  • 5. Rapid Micro Biosystems, Inc.
  • 6. Kyokuto Pharmaceutical Industrial Co., Ltd.
  • 7. Hardy Diagnostics
  • 8. SSI Diagnostica A/S
  • 9. QIAGEN N.V.
  • 10. Merck KGaA
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Liofilchem S.r.l.
  • 13. 3M Company
  • 14. Bio-Rad Laboratories, Inc.
  • 15. bioMerieux S.A.
  • 16. Abbott Laboratories
  • 17. COPAN Diagnostics Inc.
  • 18. Cardinal Health, Inc.
  • 19. Vircell S.L.
  • 20. TCS Biosciences Ltd.
  • 21. Clinichem Ltd.
  • 22. Advanced Instruments, LLC
  • 23. B. Braun SE
  • 24. Pro Lab Diagnostics Inc.
  • 25. Prestige Diagnostics U.K. Ltd.
  • 26. Laboratorios Conda, S.A.
  • 27. Becton, Dickinson and Company
  • 28. Shimadzu Corporation
  • 29. HORIBA, Ltd.
  • 30. Diagnostica Longwood S.L.

LIST OF FIGURES

  • FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 203. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023